PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer

Dr. Tweezer-Zaks Transitions from the Company’s Board of Directors to Lead Medical Strategy Following Positive Phase 3 Results and Expanding Pipeline PETACH TIKVA, Israel , Aug. 12, 2025 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (” PolyPid ” or the ” Company “), a late-stage biopharma company